Pfizer (PFE) Net Margin Growth (1y) (2010 - 2025)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Margin Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
1,568.00 |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
-2,848.00 |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
-501.00 |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-5,859.00 |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
-12.00 |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
931.00 |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
- |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
134.00 |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Jun 29, 2025 |
97.00 |
| Sep 29, 2024 |
-254.00 |
| Jun 30, 2024 |
19.00 |
| Mar 31, 2024 |
-6.00 |
| Oct 1, 2023 |
82.00 |
| Jul 2, 2023 |
-18.00 |
| Apr 2, 2023 |
6.00 |
| Oct 2, 2022 |
-4.00 |
| Jul 3, 2022 |
137.00 |
| Apr 3, 2022 |
-4.00 |
| Oct 3, 2021 |
-550.00 |
| Jul 4, 2021 |
-1,030.00 |
| Apr 4, 2021 |
-873.00 |
| Sep 27, 2020 |
542.00 |
| Sep 29, 2019 |
-5.00 |
| Dec 31, 2018 |
63,358.00 |
| Dec 31, 2017 |
-10.00 |
| Jul 2, 2017 |
1.00 |
| Dec 31, 2016 |
26.00 |
| Jul 3, 2016 |
0.00 |
| Dec 31, 2015 |
-3.00 |
| Sep 27, 2015 |
9.00 |
| Mar 29, 2015 |
-60.00 |
| Dec 31, 2014 |
31.00 |
| Sep 28, 2014 |
-11.00 |
| Mar 30, 2014 |
-56.00 |
| Dec 31, 2013 |
-2,957.00 |
| Sep 29, 2013 |
-165.00 |
| Mar 31, 2013 |
67.00 |
| Dec 31, 2012 |
1,332.00 |
| Sep 30, 2012 |
116.00 |
| Apr 1, 2012 |
47.00 |
| Dec 31, 2011 |
1,644.00 |
| Oct 2, 2011 |
42.00 |
| Jul 3, 2011 |
41.00 |
| Apr 3, 2011 |
-5.00 |
| Dec 31, 2010 |
-68.00 |
| Oct 3, 2010 |
15.00 |
| Jul 4, 2010 |
15.00 |
| Apr 4, 2010 |
11.00 |
